1 / 39

From the 6 th to the 7 th RTD Framework Programme in Biotechnology, Agriculture and Food Budapest 12 May 2005

Building Europe Knowledge. From the 6 th to the 7 th RTD Framework Programme in Biotechnology, Agriculture and Food Budapest 12 May 2005. Dr. Christian Patermann Director Biotechnology, Agriculture and Food Research European Commission, DG Research. FP6 “Food Quality and Safety”.

rhoda
Download Presentation

From the 6 th to the 7 th RTD Framework Programme in Biotechnology, Agriculture and Food Budapest 12 May 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Building Europe Knowledge From the 6th to the 7th RTD Framework Programmein Biotechnology, Agriculture and FoodBudapest 12 May 2005 Dr. Christian Patermann Director Biotechnology, Agriculture and Food Research European Commission, DG Research

  2. FP6“Food Quality and Safety” Eight areas in the Workprogramme: • Total food chain • Epidemiology of food-related diseases and allergies • Impact of food on health • Traceability processes along the production chain • Methods of analysis, detection and control • Safer and environmentally friendly production methods and technologies and healthier food stuffs • Impact of animal feed on human health • Environmental health risks

  3. Nutrient status Coeliac disease Pork quality Beef safety Unintended microorganisms Emerging traceability technologies Quality & safety control strategies Milk and dairy Food intake Health and well-being of Consumer IP NoE STREP CA Safe, high-quality foods Production Processing Crop pest control Waste management E. coli research Soil microbes for fertilizer reduction Poultry cage systems Feed safety control Plant composition analysis Processing for nutrition & environment TSE inactivation Dental disease prevention Environmental factors Asthma & allergy causes Disinfection by-products Pathogens in drinking water Food Quality and SafetyCall 4

  4. FP7 2007 - 2013 Specific Programmes Cooperation – Collaborative research Ideas – Frontier Research People – Human Potential Capacities – Research Capacity + JRC (non-nuclear) JRC (nuclear) Euratom

  5. Cooperation – Collaborative research 9 Thematic Priorities • Health • Food, agriculture and biotechnology • Information and communication technologies • Nanosciences, nanotechnologies, materials and new production technologies • Energy • Environment (including climate change) • Transport (including aeronautics) • Socio-economic sciences and the humanities • Security and space + Euratom: Fusion energy research, nuclear fission and radiation protection

  6. 2. Food, Agriculture and Biotechnology Sustainable production and management of biological resources from land, forest, and aquatic environments “Fork to farm”: Food, health and well being Life sciences and biotechnology for sustainable non-food products and processes

  7. Food, agriculture and biotechnology research:Objectives • Build a European Knowledge-Based Bio-Economy (KBBE) • Respond to social and economic challenges: • High quality food and sustainable food production • Food-related disorders (cardiovascular, obesity …) • Infectious animal diseases and zoonoses • Sustainable agriculture/fishery and climate change • Clean biomaterials from renewable bio-resources • Involve all stakeholders (incl. industry) in research • Support CAP and CFP • Respond quickly to emerging research needs

  8. Food, agriculture and biotechnology research:Rationale • Biotechnology and food companies / SMEs need to be competitive on the world market (‘European Strategy on Life Sciences and Biotechnology’) • Society demands safer and healthier food • Renewable resources and biomass for non-food applications helps reducing dependence on hydrocarbon-based economy • Society demands sustainable and eco-efficient production methods in agriculture/fishery/forestry • International cooperation ensures optimal exploitation of resources and application of results

  9. THE EUROPEAN KNOWLEDGE-BASED BIOECONOMY QUALITY ASSURANCE STRATEGIES TRACEABILITY, CONSUMER SCIENCE SOCIETAL NEEDS STABILITY - BIODEGRADABILITY FUNCTIONALITY (Chirality) Life sciences & biotechnology for sustainable non- food products + processes “Fork to Farm”Food, health and well-being WHITEBIOTECH CLEAN BIOPROCESSES RAW MATERIALS/WASTE ADVANCED FOOD TECHNOLOGIES, FOOD QUALITY DETERMINANTS, NUTRITION PROCESSING GREEN/BLUE BIOTECH OPTIMISED RAW MATERIALS LOW INPUT FARMING - BIODIVERSITY ANIMAL HEALTH - RURAL DEVT. PRODUCTION Sustainable production and management of biological resources from land, forest, and aquatic environments

  10. 1) Sustainable production and management of biological resources from land, forest, and aquatic environment Activities: • Enabling research (‘omics’, converging technologies, biodiversity) for micro-organism, plants and animals • Improved crops and production systems incl. organic farming • Sustainable, competitive and multifunctional agriculture, forestry and rural development • Animal welfare, breeding and production • Infectious diseases in animals, including zoonoses • Policy tools for agriculture and rural development

  11. 2) “Fork to farm”: Food, health and well being Activities: • Consumer, societal, industrial and health aspects of food and feed • Nutrition, diet related diseases and disorders • Innovative food and feed processing • Improved quality and safety of food, beverage and feed • Total food chain concept • Traceability

  12. 3) Life sciences and biotechnology for sustainable non-food products and processes Activities: • Improved crops, feed-stocks, marine products and biomass for energy, environment, and high added value industrial products; novel farming systems • Bio-catalysis; new bio-refinery concepts • Forestry and forest based products and processes • Environmental remediation and cleaner processing

  13. Food, agriculture and biotechnology research:What’s new! • Pillar 2 “Food, health and well-being” ensures continuity of FP6 “Food quality and safety” research • New: Pillar 1 “Sustainable production and management of biological resources” and pillar 3 “Life sciences and biotech for sustainable non-food products and processes” • Some topics under pillar 1&3 partly financed in FP4 and FP5 (BIOTECH, FAIR, QoL, etc.), but FP6 efforts scattered and not of sufficient critical mass (some activities under materials, energy and environment) providing no synergies • Technology platforms in the area of plant biotechnology, animal breeding, global animal health, forestry, food and industrial biotechnology

  14. Food, agriculture and biotechnology research:Borderline with other FP7 themes • Enabling/systems biology research on plants, animals and microbes complementary to systems biology for human health applications in theme 1. • Complementary research relating to the management/conservation of natural resources addressed under the “Environment including Climate Change” theme. • Demonstration of bioprocesses for biomass conversion to energy/materials under this priority – up-scaling and complete process design under materials and energy themes

  15. Food, agriculture and biotechnology research:NEST; policy support; international cooperation New activities within the themes: • Integration of new and emerging science and technologies • Support to policy development (CAP, CPF, public health, food safety, animal health, …) • International co-operation … to be defined on the level of the specific programme or workprogramme

  16. 1. Health Biotechnology, generic tools and technologies for human health Translating research for human health Optimising the delivery of healthcare to European citizens More on health

  17. 3. Information and Communication Technologies ICT Technology Pillars Integration of Technologies Applications Research Future and Emerging Technologies

  18. 4. Nanosciences, Nanotechnologies, Materials and new Production Technologies Nanosciences and Nanotechnologies Materials New Production Integration of technologies for industrial applications

  19. Hydrogen and fuel cells Renewable electricity generation Renewable fuel production Renewables for heating and cooling CO2 capture and storage technologies for zero emission power generation Clean coal technologies Smart energy networks Energy efficiency andsavings Knowledge for energy policy making 5. Energy

  20. 6. Environment (inc. climate change) Climate change, pollution and risks Sustainable Management of Resources Environmental Technologies Earth observation and assessment tools

  21. 7. Transport (inc. Aeronautics) Aeronautics and air transport Surface transport (rail, road and waterborne) Support to the European global satellite navigation system (Galileo)

  22. Growth, employment and competitiveness in a knowledge society Combining economic, social and environmental objectives in a European perspective Major trends in society and their implications Europe in the world The citizen in the European Union Socio-economic and scientific indicators Foresight activities 8. Socio-Economic Sciences and the Humanities

  23. Protection against terrorism and crime Space-based applications at the service of the European Society Security of infrastructures and utilities Border security Exploration of space Restoring security in case of crisis Security systems integration and interoperability RTD for strengthening space foundations Security and society Security Research Coordination and structuring 9. Security and Space

  24. Cooperation – Collaborative research • Under each theme there will be sufficient flexibility to address both Emerging needsand Unforeseen policy needs • Dissemination of knowledge and transfer of results will be supported in all thematic areas • Support will be implemented across all themes through: Collaborative research (Collaborative projects; Networks of Excellence; Coordination/support actions) Joint Technology Initiatives Coordination of non-Community research programmes (ERA-NET; ERA-NET+; Article 169) International Cooperation

  25. Joint Technology Initiatives Global Monitoring for Environment and Security Hydrogen and Fuel Cells for a Sustainable Energy Future Aeronautics and Air Transport Towards new Nanoelectronics Approaches Innovative Medicines for the Citizens of Europe Embedded systems Other possible themes to be identified later…

  26. Ideas – Frontier Research ERC – European Research Council Commission Scientific Council* • Preparation of work programme • Set up of peer review: pool of reviewers, nomination of review panels, evaluation guidelines • Oversight of the evaluation procedure • Annual scientific report • Approval of work programme, as defined by the Scientific Council • Instruction to implement work programme • Approval of annual implementation report • Information to programme committee Externalised tasks** • Information and support to applicants • Reception / eligibility of proposals • Organisation and execution of evaluation • Selection decision • Scientific and financial follow-up of contracts • Annual implementation report * Created by Commission decision * * Under the responsibility of the Commission

  27. Initial training of researchers Marie Curie Networks Life-long training and career development Individual Fellowships Co-financing of regional/national/international programmes Industry-academia pathways and partnerships Industry-Academia Scheme International dimension Outgoing International Fellowships; Incoming International Fellowships International Cooperation Scheme; Reintegration grants Specific actions Excellence awards People– Human Potential

  28. Capacities – Research Capacity • Research Infrastructures • Research for the benefit of SMEs • Regions of Knowledge • Research Potential • Science in Society • Activities of International Cooperation

  29. The instruments (1) 1) To support actions which are implemented on the basis of calls for proposals: • Collaborative projects • Networks of Excellence • Coordination/support actions • Individual projects • Fellowships • Research projects for third parties (i.a. SMEs)

  30. The instruments (2) 2) To support actions implemented directly on the basis of decisions by the Council and the European Parliament: • Art. 169 • Joint Technology Initiatives • Development of new infrastructures of European interest

  31. Roadmap for FP7 2005 6 April Commission - Adoption of FP7 proposals September Commission - Proposals on SPs and Rules for participation and dissemination November Commission - Proposals under Articles 169 and/or 171 December EP - 1st reading on EC FP. Opinion on Euratom FP 2006 January Council - Common position on EC FP March EP - 2nd reading April EP - Opinion on the Specific Programmes June Council - Adoption of FP and Rules (earliest) July Council and EP - Adoption of FP and Rules for participation July Council - Adoption of the SPs Oct Commission - Adoption of Work programmes and necessary materials Nov Commission - Publication of 1st calls

  32. Further Information FP7 on CORDIS: http://www.cordis.lu/fp7/ FP6 calls for proposals: http://fp6.cordis.lu/fp6/ Research and Innovation on the Europa server: http://europa.eu.int/pol/rd/index_de.htm DG Research: http://europa.eu.int/comm/research/index_de.html Biosociety Website:http://www.europa.eu.int/comm/research/biosociety/index_en.htm

  33. HEALTH RESEARCH Objective: • Improving the health of European citizens • Increasing the competitiveness of European health-related industries and businesses • Addressing global health issues including emerging epidemics

  34. HEALTH RESEARCH Rationale (I): • Sequencing of human genome and recent advances in post-genomics  vast amounts of data • Translational research (translation of basic discoveries in clinical applications)  to combat diseases of global importance • Clinical research  international multi-centre trials • Health policy-driven research  comparisons of the national models & data

  35. HEALTH RESEARCH Rationale (II): • Strong EU-based biomedical and research  to strengthen the competitiveness of large industries (pharma) as well as SMEs (healthcare biotech & medical technology) • Child health and the health of the ageing population  strategic issues across activities • European Technology Platform on Innovative Medicines  to remove bottlenecks hampering the efficiency of the development of new medicines and where research is the key

  36. HEALTH RESEARCH Activities: • Biotechnology, generic tools and technologies for human health • Translating research for human health • Optimising the delivery of health care to European citizens

  37. HEALTH RESEARCH Biotechnology, generic tools and technologies for human health • High-throughput research • Detection, diagnosis and monitoring. • Predicting suitability, safety and efficacy of therapies (incl. alternatives to animal testing) • Innovative therapeutic approaches and intervention

  38. HEALTH RESEARCH Translating research for human health • Integrating biological data and processes: large-scale data gathering, systems biology • Research on the brain and related diseases, human development and ageing • Translational research in infectious diseases (incl. HIV/AIDS, malaria, tuberculosis, SARS, etc.) • Translational research in major diseases: cancer, cardiovascular disease, diabetes/obesity; rare diseases; and other chronic diseases (e.g. osteoarthritis).

  39. HEALTH RESEARCH Optimising the delivery of health care to European citizens • Translating clinical outcome into clinical practice • Quality, efficiency and solidarity of health systems including transitional health systems (i.e. health systems that are currently under a reform process) • Enhanced disease prevention and better use of medicines • Appropriate use of new health therapies and technologies Return to main presentation

More Related